{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:53:07Z","timestamp":1790805187104,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1991,8,1]],"date-time":"1991-08-01T00:00:00Z","timestamp":681004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology"],"published-print":{"date-parts":[[1991,8]]},"DOI":"10.1016\/0030-4220(91)90160-e","type":"journal-article","created":{"date-parts":[[2006,9,21]],"date-time":"2006-09-21T11:29:06Z","timestamp":1158838146000},"page":"178-183","source":"Crossref","is-referenced-by-count":9,"title":["Determining therapeutic efficacy in recurrent herpes labialis by lesion size analysis"],"prefix":"10.1016","volume":"72","author":[{"given":"Brad","family":"Rodu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl M.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Mattingly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/0030-4220(91)90160-E_bib1","series-title":"Antiviral agents and viral diseases of man","first-page":"247","article-title":"Dermatologic viral diseases","author":"Overall","year":"1984"},{"key":"10.1016\/0030-4220(91)90160-E_bib2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM197310112891505","article-title":"Infection with herpes-simplex viruses 1 and 2","volume":"289","author":"Nahmias","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1016\/0030-4220(91)90160-E_bib3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0030-4220(76)90277-2","article-title":"A clinical study for the control of facial mucocutaneous herpes virus infections. I. Characterization of natural history in a professional school population","volume":"41","author":"Young","year":"1976","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/0030-4220(91)90160-E_bib4","first-page":"627","article-title":"Prevalence of recurrent herpes labialis and aphthous ulcers among young adults on six continents","volume":"113","author":"Embil","year":"1975","journal-title":"Can Med Assoc J"},{"key":"10.1016\/0030-4220(91)90160-E_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.14219\/jada.archive.1967.0276","article-title":"The patient with recurrent aphthous ulcers and the patient with recurrent herpes labialis: a study of two population samples","volume":"75","author":"Ship","year":"1967","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/0030-4220(91)90160-E_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM197707142970201","article-title":"The natural history of recurrent herpes simplex labialis: implications for antiviral therapy","volume":"197","author":"Spruance","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/0030-4220(91)90160-E_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7326\/0003-4819-96-3-265","article-title":"Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind study","volume":"96","author":"Wade","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/0030-4220(91)90160-E_bib8","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(81)92569-1","article-title":"Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients","volume":"1","author":"Mitchell","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/0030-4220(91)90160-E_bib9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-96-3-270","article-title":"Acyclovir for chronic mucocutaneous herpes simplex virus infections in immunosuppressed patients","volume":"96","author":"Straus","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/0030-4220(91)90160-E_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/infdis\/150.3.323","article-title":"Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy","volume":"150","author":"Whitley","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/0030-4220(91)90160-E_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM198902023200506","article-title":"Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome","volume":"320","author":"Erlich","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/0030-4220(91)90160-E_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/infdis\/146.1.85","article-title":"Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol","volume":"146","author":"Spruance","year":"1982","journal-title":"J Infect Dis"},{"key":"10.1016\/0030-4220(91)90160-E_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/bmj.291.6487.7","article-title":"Failure of acyclovir cream in treatment of recurrent herpes labialis","volume":"291","author":"Shaw","year":"1985","journal-title":"Br Med J"},{"key":"10.1016\/0030-4220(91)90160-E_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJM198202113060606","article-title":"Resistance to antiviral drugs of herpes simplex isolated from a patient treated with acyclovir","volume":"306","author":"Crumpacker","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/0030-4220(91)90160-E_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0140-6736(82)91620-8","article-title":"Isolation and characterisation of resistant herpes simplex virus after acyclovir therapy","volume":"1","author":"Burns","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/0030-4220(91)90160-E_bib16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1600-0714.1988.tb01544.x","article-title":"In vitro virucidal activity by components of a topical film-forming medication","volume":"17","author":"Rodu","year":"1988","journal-title":"J Oral Pathol"},{"key":"10.1016\/0030-4220(91)90160-E_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jmv.1890150110","article-title":"Antiviral effect of flavonoids on human viruses","volume":"15","author":"Kaul","year":"1985","journal-title":"J Med Virol"},{"key":"10.1016\/0030-4220(91)90160-E_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0166-3542(89)90038-7","article-title":"Inhibition of herpes simplex virus infection by tannins and related compounds","volume":"11","author":"Fukuchi","year":"1989","journal-title":"Antiviral Res"},{"key":"10.1016\/0030-4220(91)90160-E_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.14219\/jada.archive.1987.0211","article-title":"Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study","volume":"115","author":"Raborn","year":"1987","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/0030-4220(91)90160-E_bib20","first-page":"329","article-title":"Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study","volume":"138","author":"Lawee","year":"1988","journal-title":"Can Med Assoc J"},{"key":"10.1016\/0030-4220(91)90160-E_bib21","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/infdis\/154.6.930","article-title":"Iontophoresis of vidarabine monophosphate for herpes orolabialis","volume":"154","author":"Gangarosa","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/0030-4220(91)90160-E_bib22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/AAC.25.5.553","article-title":"Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir","volume":"25","author":"Spruance","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/0030-4220(91)90160-E_bib23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000250926","article-title":"A multicentered study of lysine therapy in herpes simplex infection","volume":"156","author":"Griffith","year":"1978","journal-title":"Dermatologica"},{"key":"10.1016\/0030-4220(91)90160-E_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.1984.01650370054010","article-title":"Failure of lysine in frequently recurrent herpes simplex infection: treatment and prophylaxis","volume":"120","author":"DiGiovanna","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/0030-4220(91)90160-E_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/jama.1973.03220030027005","article-title":"Photodynamic inactivation of herpes simplex: report of a clinical trial","volume":"223","author":"Felber","year":"1973","journal-title":"JAMA"},{"key":"10.1016\/0030-4220(91)90160-E_bib26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5694\/j.1326-5377.1975.tb111504.x","article-title":"Topical treatment of recurrent herpes simplex with cytosine arabinoside","volume":"1","author":"Marks","year":"1975","journal-title":"Med J Aust"},{"key":"10.1016\/0030-4220(91)90160-E_bib27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/infdis\/137.5.597","article-title":"A double-blind, controlled trial of levamisole in the treatment of recurrent herpes labialis","volume":"137","author":"Russell","year":"1978","journal-title":"J Infect Dis"},{"key":"10.1016\/0030-4220(91)90160-E_bib28","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.1980.03300360031020","article-title":"Topical ether and herpes simplex labialis","volume":"243","author":"Guinan","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/0030-4220(91)90160-E_bib29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0030-4220(88)90013-8","article-title":"Performance of a hydroxypropyl cellulose film former in normal and ulcerated oral mucosa","volume":"65","author":"Rodu","year":"1988","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/0030-4220(91)90160-E_bib30","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1600-0714.1988.tb01335.x","article-title":"Clinical and chemical properties of a novel mucosal bioadhesive agent","volume":"17","author":"Rodu","year":"1988","journal-title":"J Oral Pathol"},{"key":"10.1016\/0030-4220(91)90160-E_bib31","first-page":"483","article-title":"Inhibition of multiplication of influenza virus by tannic acid","volume":"67","author":"Green","year":"1948"},{"key":"10.1016\/0030-4220(91)90160-E_bib32","first-page":"84","article-title":"Inhibition of multiplication of influenza virus by extracts of tea","volume":"71","author":"Green","year":"1949"},{"key":"10.1016\/0030-4220(91)90160-E_bib33","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/BF00621446","article-title":"Inhibitory activity of tannic acid and flavonols on the infectivity of herpesvirus hominis and herpesvirus suis","volume":"52","author":"Beladi","year":"1965","journal-title":"Naturwissenschaften"},{"key":"10.1016\/0030-4220(91)90160-E_bib34","first-page":"245","article-title":"New treatment for herpes simplex virus type 2 (ultrasound and zinc, urea, and tannic acid ointment)","volume":"9","author":"Fahim","year":"1978","journal-title":"J Med"},{"key":"10.1016\/0030-4220(91)90160-E_bib35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1749-6632.1977.tb21971.x","article-title":"Activity of some flavonoids against viruses","volume":"284","author":"Beladi","year":"1977","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/0030-4220(91)90160-E_bib36","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1348-0421.1979.tb00507.x","article-title":"Effects of tannic acid and its related compounds upon chikungunya virus","volume":"23","author":"Konishi","year":"1979","journal-title":"Microbiol Immunol"},{"key":"10.1016\/0030-4220(91)90160-E_bib37","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/bmj.2.6192.704","article-title":"Possible treatment for cold sores","volume":"2","author":"Skinner","year":"1979","journal-title":"[Letter]. Br Med J"},{"key":"10.1016\/0030-4220(91)90160-E_bib38","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/00220345660450037501","article-title":"Effect of keratolytic drugs on oral hyperkeratosis in Syrian hamsters","volume":"45","author":"Capodanno","year":"1966","journal-title":"J Dent Res"},{"key":"10.1016\/0030-4220(91)90160-E_bib39","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/jps.2600671213","article-title":"Effect of repeated skin application on percutaneous absorption of salicylic acid","volume":"67","author":"Roberts","year":"1978","journal-title":"J Pharm Sci"},{"key":"10.1016\/0030-4220(91)90160-E_bib40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ijd.1979.18.3.228","article-title":"Systemic absorption of topical salicylic acid","volume":"18","author":"Birmingham","year":"1979","journal-title":"Int J Dermatol"},{"key":"10.1016\/0030-4220(91)90160-E_bib41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0041-008X(85)90311-4","article-title":"Percutaneous absorption in man: a kinetic approach","volume":"78","author":"Guy","year":"1985","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/0030-4220(91)90160-E_bib42","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000251346","article-title":"Dermatopharmacology of salicylic acid. I. Range of dermatotherapeutic effects of salicylic acid","volume":"151","author":"Weirich","year":"1975","journal-title":"Dermatologica"},{"key":"10.1016\/0030-4220(91)90160-E_bib43","series-title":"The pharmacological basis of therapeutics","first-page":"674","article-title":"Analgesic-antipyretics and anti-inflammatory agents: drugs employed in the treatment of gout","author":"Flower","year":"1985"},{"key":"10.1016\/0030-4220(91)90160-E_bib44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000251167","article-title":"Dermatopharmacology of salicylic acid. III. Topical contrainflammatory effect of salicylic acid and other drugs in animal experiments","volume":"152","author":"Weirich","year":"1976","journal-title":"Dermatologica"},{"key":"10.1016\/0030-4220(91)90160-E_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(85)90491-1","article-title":"The anti-oedematogenic effect of SRS as an additional factor in the mode of action of nonsteroid antiinflammatory drugs","volume":"112","author":"Jancar","year":"1985","journal-title":"Eur J Pharmacol"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:003042209190160E?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:003042209190160E?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T08:51:47Z","timestamp":1587199907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/003042209190160E"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,8]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1991,8]]}},"alternative-id":["003042209190160E"],"URL":"https:\/\/doi.org\/10.1016\/0030-4220(91)90160-e","relation":{},"ISSN":["0030-4220"],"issn-type":[{"value":"0030-4220","type":"print"}],"subject":[],"published":{"date-parts":[[1991,8]]}}}